FIGUR8, Inc.

FIGUR8, Inc. is a Massachusetts-based company founded in 2017 that specializes in musculoskeletal (MSK) health assessment. The company has developed the bioMotion Assessment Platform (bMAP), which is the first FDA-registered tool designed to provide accurate and objective MSK assessments. This platform captures lab-grade biomechanics data in clinical settings, helping to standardize health and injury recovery data.

FIGUR8's technology enhances communication between providers and patients, streamlining the management of claims and optimizing recovery for injured workers. The platform supports personalized recovery pathways and physical performance monitoring, contributing to faster recovery and improved claims precision. Recently, FIGUR8 secured $25 million in Series A-1 funding to support its growth. The company is committed to high standards of care, as evidenced by its pledge to ensure services are performed by licensed physical therapists.